Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.06−1.42 (-7.68%)
Close on Nov 17, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care total assets
Total assets on the balance sheet at the end of each period.
Tandem Diabetes Care's total assets was $1.15B at Jun 30, 2026. For fiscal 2025 it was $881.11M, down 8.9% from the year before. Over ten years it grew 21.6% a year on average. The highest annual figure on record is $1.05B in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $881.11M | -8.9% |
| FY2024 | Dec 31, 2024 | $967.66M | +1.6% |
| FY2023 | Dec 31, 2023 | $952.66M | -9.5% |
| FY2022 | Dec 31, 2022 | $1.05B | +16.3% |
| FY2021 | Dec 31, 2021 | $905.14M | +26.3% |
| FY2020 | Dec 31, 2020 | $716.42M | +119.7% |
| FY2019 | Dec 31, 2019 | $326.11M | +58.1% |
| FY2018 | Dec 31, 2018 | $206.29M | +116.4% |
| FY2017 | Dec 31, 2017 | $95.35M | -15.2% |
| FY2016 | Dec 31, 2016 | $112.39M | -9.9% |
| FY2015 | Dec 31, 2015 | $124.73M | +17.2% |
| FY2014 | Dec 31, 2014 | $106.46M | -34.4% |
| FY2013 | Dec 31, 2013 | $162.22M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.15B | +31.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.15B | +25.1% |
| Q4 FY2025 | Dec 31, 2025 | $881.11M | -8.9% |
| Q3 FY2025 | Sep 30, 2025 | $874.65M | -8.7% |
| Q2 FY2025 | Jun 30, 2025 | $875.74M | -6.6% |
| Q1 FY2025 | Mar 31, 2025 | $922.14M | -2.0% |
| Q4 FY2024 | Dec 31, 2024 | $967.66M | +1.6% |
| Q3 FY2024 | Sep 30, 2024 | $957.73M | +1.9% |
| Q2 FY2024 | Jun 30, 2024 | $937.50M | -1.0% |
| Q1 FY2024 | Mar 31, 2024 | $941.05M | -1.4% |
| Q4 FY2023 | Dec 31, 2023 | $952.66M | -9.5% |
| Q3 FY2023 | Sep 30, 2023 | $939.91M | -10.3% |
| Q2 FY2023 | Jun 30, 2023 | $946.68M | -8.7% |
| Q1 FY2023 | Mar 31, 2023 | $954.15M | -6.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.05B | +16.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.05B | +23.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.04B | +30.3% |
| Q1 FY2022 | Mar 31, 2022 | $1.02B | +34.6% |
| Q4 FY2021 | Dec 31, 2021 | $905.14M | +26.3% |
| Q3 FY2021 | Sep 30, 2021 | $850.28M | +26.3% |
| Q2 FY2021 | Jun 30, 2021 | $795.25M | +29.0% |
| Q1 FY2021 | Mar 31, 2021 | $754.27M | +119.7% |
| Q4 FY2020 | Dec 31, 2020 | $716.42M | +119.7% |
| Q3 FY2020 | Sep 30, 2020 | $672.99M | +130.0% |
| Q2 FY2020 | Jun 30, 2020 | $616.24M | +141.6% |
| Q1 FY2020 | Mar 31, 2020 | $343.33M | +59.9% |
| Q4 FY2019 | Dec 31, 2019 | $326.11M | +58.1% |
| Q3 FY2019 | Sep 30, 2019 | $292.65M | +61.1% |
| Q2 FY2019 | Jun 30, 2019 | $255.08M | +61.4% |
| Q1 FY2019 | Mar 31, 2019 | $214.70M | +48.4% |
| Q4 FY2018 | Dec 31, 2018 | $206.29M | +116.4% |
| Q3 FY2018 | Sep 30, 2018 | $181.61M | +106.4% |
| Q2 FY2018 | Jun 30, 2018 | $157.99M | +60.3% |
| Q1 FY2018 | Mar 31, 2018 | $144.70M | +28.4% |
| Q4 FY2017 | Dec 31, 2017 | $95.35M | -15.2% |
| Q3 FY2017 | Sep 30, 2017 | $87.98M | -2.6% |
| Q2 FY2017 | Jun 30, 2017 | $98.54M | – |
| Q1 FY2017 | Mar 31, 2017 | $112.71M | – |
| Q4 FY2016 | Dec 31, 2016 | $112.39M | – |
| Q3 FY2016 | Sep 30, 2016 | $90.33M | – |
See a number that looks wrong?